Owner Toray Industries, Inc.

Inventors Takaki, Suguru; Ohta, Kotoe; Horiuchi, Yasuhide

Agent Davies Collison Cave

Pub. Number AU-A-2010231701

PCT Pub. Number WO2010/113841

Priority 2009-081916 30.03.09 JP

Filing date 29 March 2010

Wipo publication date 7 October 2010

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/133 (2006.01) - having hydroxy groups, e.g. sphingosine

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

A61K 31/4439 (2006.01)

A61K 31/4515 (2006.01) - having a butyrophenone group in position 1, e.g. haloperidol

A61K 31/5517 (2006.01)

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 25/20 (2006.01) Drugs for disorders of the nervous system